[What is to be done with vancomycin-resistant enterococcal infections?]
- PMID: 11191789
[What is to be done with vancomycin-resistant enterococcal infections?]
Abstract
Recently, three epidemics in Dutch hospitals were caused by vancomycin-resistant enterococci (VRE). Although the number of infections was small, spread of colonization was extensive and many infection control measures were necessary to prevent further spread. VRE are relatively avirulent bacteria. However, few, if any, antibiotics are available for treatment of infections caused by VRE and the genetic code for resistance may be transferable to other, more virulent, bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Although colonization and infection with MRSA have become endemic in many surrounding countries, such a situation has been prevented in the Netherlands by employing an aggressive 'search and destroy' policy. Although many questions regarding the optimal approach of VRE remain unanswered, a similar policy as employed for MRSA will not be possible. In contrast to MRSA, colonization with VRE occurs in the open population, no populations with increased risk for colonization appear to be definable and colonization cannot be eradicated. Based on common sense, a differentiated approach seems indicated in which extensive infection control measures should only be implemented when spread of a single genotype has been demonstrated. A reference laboratory should be created for uniform genotyping.
Comment in
-
[Epidemiologic increase of various genotypes of vancomycin-resistant Enterococcus faecium in a university hospital].Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2572-6. Ned Tijdschr Geneeskd. 2000. PMID: 11191796 Dutch.
Similar articles
-
[Vancomycin resistant enterococci in the Netherlands].Ned Tijdschr Geneeskd. 2004 May 1;148(18):878-82. Ned Tijdschr Geneeskd. 2004. PMID: 15152389 Review. Dutch.
-
Vancomycin-resistant enterococci: consequences for therapy and infection control.Clin Microbiol Infect. 2005 Jul;11 Suppl 4:43-56. doi: 10.1111/j.1469-0691.2005.01164.x. Clin Microbiol Infect. 2005. PMID: 15953021 Review.
-
Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.Chin Med J (Engl). 2009 Jun 5;122(11):1283-8. Chin Med J (Engl). 2009. PMID: 19567138
-
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i17-28. doi: 10.1093/jac/dkn250. J Antimicrob Chemother. 2008. PMID: 18684703 Clinical Trial.
-
[Epidemiologic increase of various genotypes of vancomycin-resistant Enterococcus faecium in a university hospital].Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2572-6. Ned Tijdschr Geneeskd. 2000. PMID: 11191796 Dutch.
Cited by
-
What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?BMJ. 2002 Mar 16;324(7338):666-8. doi: 10.1136/bmj.324.7338.666. BMJ. 2002. PMID: 11895829 Free PMC article. Review. No abstract available.
-
[Epidemiology of and preventive measures for multiresistant pathogens].Ophthalmologe. 2010 Apr;107(4):313-7. doi: 10.1007/s00347-009-2074-2. Ophthalmologe. 2010. PMID: 20306054 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical